Ram E, Sternik L, Klempfner R, et al. - Researchers determined how diabetes mellitus (DM) type 2, and its treatment subgroups, could influence short- and long-term death in patients suffering from acute coronary syndrome (ACS) who underwent coronary artery bypass grafting (CABG). This analysis involved 1,307 patients enrolled from the biennial Acute Coronary Syndrome Israeli Survey between 2000 and 2016, who got hospitalized for ACS and were treated with CABG. Of those, DM was present in 527 (40%) patients and 780 (60%) were free of DM. Findings revealed no impact of type 2 DM on in-hospital mortality hazard but the presence of DM in ACS patients referred to CABG was identified as a powerful risk factor for long-term death, particularly when insulin was incorporated in the diabetic treatment strategy.